Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons A.G.H. Niezink

Publicaties

Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy

Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma

External validation of NTCP-models for radiation pneumonitis in lung cancer patients treated with chemoradiotherapy

Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy

MO-0960 Evaluating semi-automated 18F-FDG PET segmentation methods to predict Large B-cell lymphoma outcomes

Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities

Reduction of Metabolic Active Tumor Volume Prior to CAR T-Cell Therapy Improves Survival Outcomes in Patients with Large B-Cell Lymphoma

Semi-automated 18F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation

The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands

Durvalumab increases the risk of radiation pneumonitis in non-small-cell lung cancer patients

Lees meer

Pers/media

Protonentherapie voor mediastinale lymfomen